Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis

Lancet

Volumn 351, Issue 9107, 1998, Pages 978-981

  Pender, Michael P ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIGEN; MYELIN; SUPERANTIGEN;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; DEMYELINATION; DISEASE COURSE; GENETIC PREDISPOSITION; GENETICS; HUMAN; LYMPHOID ORGAN; MULTIPLE SCLEROSIS; NERVE FIBER; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032495663     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60642-3     Document Type: Note

References (20)

1. 1 Martin R, Jaraquemada D, Flerlage M, et al. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 1990; 145: 540-48.
2. 2 Schluesener HJ, Wekerle H. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. J Immunol 1985; 135: 3128-33.
3. 3 Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
4. 4 Wekerle H, Linington C, Lassmann H, et al. Cellular immune reactivity within the CNS. Trends Neurosci 1986; 9: 271-77.
5. 5 Pender MP, Nguyen KB, McCombe PA, et al. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 1991; 104: 81-87.
6. 6 Pender MP, McCombe PA, Yoong G, et al. Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J Autoimmun 1992; 5: 401-10.
7. 7 Schmied M, Breitschopf H, Gold R, et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993; 143: 446-52.
8. 8 Tabi Z, McCombe PA, Pender MP. Apoptotic elimination of Vβ8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of Vβ8.2+ encephalitogenic T cells. Eur J Immunol 1994; 24: 2609-17.
9. 9 Tabi Z, McCombe PA, Pender MP. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int Immunol 1995; 7: 967-73.
10. 10 White CA, McCombe PA, Pender MP. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J Neuroimmunol 1998; 82: 47-55.
11. 11 Ozawa K, Suchanek G, Breitschopf H, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117: 1311-22.
12. 12 Dowling P, Husar W, Menonna J, et al. Cell death and birth in multiple sclerosis brain. J Neurol Sci 1997; 149: 1-11.
13. 13 Pender MP, Sears TA. The pathophysiology of acute experimental allergic encephalomyelitis in the rabbit. Brain 1984; 107: 699-726.
14. 14 Chalk JB, McCombe PA, Pender MP. Conduction abnormalities are restricted to the central nervous system in experimental autoimmune encephalomyelitis induced by inoculation with proteolipid protein but not with myelin basic protein. Brain 1994; 117: 975-86.
15. 15 Greer JM, Csurhes PA, Cameron KD, et al. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. Brain 1997; 120: 1447-60.
16. 16 Tuohy VK, Yu M, Guttman B, et al. Diversity and plasticity of self-determinant recognition during the early development of multiple sclerosis. Ann Neural 1996; 40: 519.
17. 17 Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain 1997; 120: 1085-96.
18. 18 Acarin N, Rio J, Fernandez AL, et al. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis. Acta Neurol Scand 1996; 93: 99-103.
19. 19 Bell JI, Lathrop GM. Multiple loci for multiple sclerosis. Nature Genet 1996; 13: 377-78.
20. 20 Pender MP. Multiple sclerosis. In: Pender MP, McCombe PA, eds. Autoimmune neurological disease. Cambridge: Cambridge University Press, 1995: 89-154.